Measurable residual disease as a biomarker in acute myeloid leukemia: theoretical and practical considerations-Reference-Cited by-同舟云学术

Measurable residual disease as a biomarker in acute myeloid leukemia: theoretical and practical considerations

Published:2021-03-23 Issue:6 Volume:35 Page:1529-1538
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Walter Roland B.^ORCID,Ofran Yishai,Wierzbowska Agnieszka,Ravandi Farhad,Hourigan Christopher S.,Ngai Lok Lam^ORCID,Venditti Adriano^ORCID,Buccisano Francesco,Ossenkoppele Gert J.,Roboz Gail J.

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/s41375-021-01230-4.pdf

Reference68 articles.

1. Hagenbeek A, Martens ACM. Kinetics of minimal residual disease in a rat model for human acute myelocytic leukemia. In: Baum SJ, Ledney GD, van Bekkum DW, editors. Experimental hematology today. New York: Springer; 1980. p. 215–21.

2. Hagenbeek A, Martens ACM. Minimal residual disease in acute leukemia: from experimental models to man. Bone Marrow Transplant. 1989;4:68–9.

3. Freireich EJ, Cork A, Stass SA, McCredie KB, Keating MJ, Estey EH, et al. Cytogenetics for detection of minimal residual disease in acute myeloblastic leukemia. Leukemia. 1992;6:500–6.

4. Schuurhuis GJ, Heuser M, Freeman S, Béné MC, Buccisano F, Cloos J, et al. Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working Party. Blood. 2018;131:1275–91.

5. Hourigan CS, Gale RP, Gormley NJ, Ossenkoppele GJ, Walter RB. Measurable residual disease testing in acute myeloid leukaemia. Leukemia. 2017;31:1482–90.

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Artificial intelligence reveals the predictions of hematological indexes in children with acute leukemia;BMC Cancer;2024-08-12

2. Mass cytometric single cell immune profiles of peripheral blood from acute myeloid leukemia patients in complete remission with measurable residual disease;Cytometry Part B: Clinical Cytometry;2024-07-30

3. Measurable residual disease in haematological and solid cancers;Leukemia;2024-06-27

4. Increased Th17 and Treg levels in peripheral blood positively correlate with minimal residual disease in acute myeloid leukaemia;Hematology;2024-04-29

5. Measurable Residual Disease Detection in Acute Myeloid Leukemia: Current Challenges and Future Directions;Biomedicines;2024-03-07